Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers
The biotech’s liver-disease treatment is also viewed as best-in-class, earning it a full slate of buy ratings from analysts.
What's Your Reaction?







Chatty News Dec 7, 2024 0 38
Chatty News Nov 18, 2024 0 35
Chatty News Nov 20, 2024 0 31
Chatty News Nov 26, 2024 0 31
Chatty News Dec 26, 2024 0 28
Chatty News Nov 18, 2024 0 18
Chatty News Nov 18, 2024 0 20
Chatty News Nov 18, 2024 0 20
Total Vote: 5
Yes